Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
BMJ Case Reports
|
September 19, 2013
A 52-year-old-male patient with metastatic non-small-cell lung cancer and recurrent venous thromboembolism in unusual sites despite anticoagulation
Alexios Matikas, Nikolaos Vardakis, John Souglakos, et al.
Sensors (Basel, Switzerland)
|
July 30, 2025
Rapid and Accurate Shape-Sensing Method Using a Multi-Core Fiber Bragg Grating-Based Optical Fiber
Georgios Violakis, Nikolaos Vardakis, Zhenyu Zhang, et al.
Journal of Geriatric Oncology
|
January 9, 2025
Adjuvant taxane-based chemotherapy treatment in older patients with early breast cancer: A pooled analysis of five phase III trials from the Hellenic Oncology Research Group
Oraianthi Fiste, Lambros Vamvakas, Panagiotis Katsaounis, et al.
Anticancer Research
|
March 2, 2005
A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer
Charalambos Kouroussis, Konstantinos Kalbakis, Nikolaos Androulakis, et al.
Cancer Chemotherapy and Pharmacology
|
May 6, 2009
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors
Zacharenia Saridaki, Periklis Pappas, John Souglakos, et al.
Oncology
|
January 15, 2009
Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study
Charalambos Kouroussis, Lambros Vamvakas, Nikolaos Vardakis, et al.
Minerva Ginecologica
|
February 8, 2019
Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study
John Syrios, Charalambos Kouroussis, Athanasios Kotsakis, et al.
Cancer Chemotherapy and Pharmacology
|
September 11, 2010
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
Nikolaos Xenidis, Nikolaos Vardakis, Ioannis Varthalitis, et al.
Cancer Investigation
|
October 6, 2005
A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors
John Souglakos, Stylianos Kakolyris, Nikolaos Vardakis, et al.
Journal of Chemotherapy (Florence, Italy)
|
February 26, 2013
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group
Emmanouil Kontopodis, Dora Hatzidaki, Ioannis Varthalitis, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
BMJ Case Reports
|
September 19, 2013
A 52-year-old-male patient with metastatic non-small-cell lung cancer and recurrent venous thromboembolism in unusual sites despite anticoagulation
Alexios Matikas, Nikolaos Vardakis, John Souglakos, et al.
Sensors (Basel, Switzerland)
|
July 30, 2025
Rapid and Accurate Shape-Sensing Method Using a Multi-Core Fiber Bragg Grating-Based Optical Fiber
Georgios Violakis, Nikolaos Vardakis, Zhenyu Zhang, et al.
Journal of Geriatric Oncology
|
January 9, 2025
Adjuvant taxane-based chemotherapy treatment in older patients with early breast cancer: A pooled analysis of five phase III trials from the Hellenic Oncology Research Group
Oraianthi Fiste, Lambros Vamvakas, Panagiotis Katsaounis, et al.
Anticancer Research
|
March 2, 2005
A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer
Charalambos Kouroussis, Konstantinos Kalbakis, Nikolaos Androulakis, et al.
Cancer Chemotherapy and Pharmacology
|
May 6, 2009
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors
Zacharenia Saridaki, Periklis Pappas, John Souglakos, et al.
Oncology
|
January 15, 2009
Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study
Charalambos Kouroussis, Lambros Vamvakas, Nikolaos Vardakis, et al.
Minerva Ginecologica
|
February 8, 2019
Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study
John Syrios, Charalambos Kouroussis, Athanasios Kotsakis, et al.
Cancer Chemotherapy and Pharmacology
|
September 11, 2010
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer
Nikolaos Xenidis, Nikolaos Vardakis, Ioannis Varthalitis, et al.
Cancer Investigation
|
October 6, 2005
A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors
John Souglakos, Stylianos Kakolyris, Nikolaos Vardakis, et al.
Journal of Chemotherapy (Florence, Italy)
|
February 26, 2013
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group
Emmanouil Kontopodis, Dora Hatzidaki, Ioannis Varthalitis, et al.
Page
of 4